Dublin, Ireland-based contract research organization (CRO) ICON received industry accreditations for three of its laboratories in the UK and Singapore, and Newark, Del.-based QPS received a Good Laboratory Practice (GLP) certificate for its Taiwan operations.
ICON’s bioanalytical laboratory in Manchester, UK, received GCP and GLP accreditation from the Medicines and Healthcare products Regulatory Agency, while the CRO’s clinical pathology laboratory in Manchester received GCP accreditation. ICON now has two GLP-accredited bioanalytical laboratories, following the company’s acquisition of U.S.-based Prevalere Life Sciences in November 2008.
The CRO’s central laboratory in Singapore was awarded the Level I Certificate of Traceability by the National Glycohemoglobin Standardisation Program.
QPS was awarded a GLP-laboratory certification for QPS Taiwan, the company’s Asian operation. According to QPS, the certification, given by the Department of Health (DOH), Executive Yuan, R.O.C. (Taiwan), is the first and only GLP-laboratory certification given by the DOH, Taiwan, for bioanalytical services supporting preclinical and clinical research.